Modalis Therapeutics Corporation
Modalis is a drug development company that utilizes CRISPR technology, a platform technology provision.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Modalis Therapeutics Corporation Information
Geographic Data
Address: 3-11-5 Nihonbashihoncho
City: Chuo-ku
State: tōkyō prefecture
Zip: 103-0023
Country: JP
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Contact Phone:
Contact Email:
Modalis Therapeutics Corporation went public on the Tokyo Stock Exchange
Listed Exchange:
Tokyo Stock Exchange
Ticker Symbol:
48830
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
